8th Nov 2006 07:01
Advanced Medical Solutions Grp PLC08 November 2006 For immediate release 8 November 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") Partnership with BSN medical and AT3 European launch of novel wound closure product Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalmedical technology company, today announces that it has entered into apartnership with AT3, a Canadian technology company, and BSN medical, a globalmedical device company, for manufacturing and distribution of Leukosan(R)SkinLink, a novel wound closure product. Leukosan(R) SkinLink consists of a perforated adhesive closure strip on whichcyanoacrylate topical glue is applied to produce a non-invasive system forclosing trauma wounds in Accident and Emergency and surgical incisions in theOperating Room. SkinLink offers significant benefits over current closuremethods such as sutures, staples or strips. This strong wound closure system isas reliable as conventional methods, yet requires no anesthesia, stitching orstapling and therefore adds no further trauma to the wound. This patented woundclosing procedure is easy to learn and quick to apply and represents asignificant time saving in the closure and overall treatment of cuts andincisions. Montreal based AT3 owns the Intellectual Property rights covering SkinLink. AMShas been granted exclusive distribution rights to the UK and an exclusivemanufacturing licence to supply the product for other markets. BSN medical ofHamburg, Germany, acquired an exclusive marketing licence for the product forall European countries outside the UK. BSN medical has recently launchedSkinLink throughout Europe under its Leukosan(R) brand and plans to market it inmore than twenty countries around the world. Commenting on today's announcement Dr. Don Evans, Chief Executive of AMS,stated: "I am pleased that we have been able to obtain exclusive manufacturing rights tothis novel technology. We have been selling this product in the UK since 2005as part of our wound closure portfolio and look forward to supplying BSN medicalacross the world." Jean Matteau, President of AT3, added: "We are delighted to have signed licensing deals with companies of the calibreof AMS and BSN medical which provides strong validation of our SkinLinktechnology, confirming our own experience in Canada." Dr. Claus Wiegel, Global Commercial Director of BSN medical, said: "The launch plans were very ambitious and we are pleased that we were able tomeet the expectations thanks to the joint effort of this internationalpartnership." -ENDS- For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in1991 and currently quoted on AIM, Advanced Medical Solutions is focused on thedesign, development and manufacture of innovative and technologically advancedproducts for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS's technology and products currently serve the majority of the key globalmarkets and strategic partners. AT3 is a privately held company of new medical technologies who acquired theIntellectual Property covering SkinLink at the beginning of 2006. The companyhas successfully developed a competitive and patent protected wound closuredevice which represent the next generation of skin closure technology. AT3'svision is to establish its skin closure system as the new standard of care forclosing surgical incisions and traumatic wounds. BSN medical is a global leader in the worldwide healthcare market specializingin the areas of Wound Care, Orthopaedics and Phlebology. The company is focusedon the development of world-class branded products which offer high qualitysolutions for caregivers and patients. BSN medical was originally formed as a joint venture in 2001 between Beiersdorf,Inc. and Smith & Nephew, Inc. In early 2006, BSN medical became a fullyindependent player. BSN medical employs almost 3500 people worldwide andmaintains manufacturing facilites in Germany, France, Mexico, New Zealand, SouthAfrica, the UK, the US and other countries; sales and marketing organisationsoperate in the largest markets. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group